UPDATE: Citigroup Raises PT on Cynosure Following 2Q13 Results Report

In a report published Thursday, Citigroup analyst Matthew J. Dodds reiterated a Buy rating on Cynosure (NASDAQ: CYNO ), and raised the price target from $36.00 to $41.00. In the report, Citigroup noted, “2Q13 results were ahead of our and the Street's expectations as the impact of the late quarter